martes, 26 de enero de 2021

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action - The Lancet Respiratory Medicine

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario